Association of Systemic Inflammatory and Metabolic Biomarkers with Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes: A Prospective Cohort Study
Inflammatory and Metabolic Risk Profiling in Type 2 Diabetes
DOI:
https://doi.org/10.69750/dmls.03.08.0224Keywords:
Type 2 diabetes mellitus, MACE, systemic inflammation, hs-CRP, systemic immune-inflammation index, triglyceride-glucose index, cardiovascular riskAbstract
Background: Cardiovascular complications continue to occur in type 2 diabetes mellitus (T2DM) despite treatment of established risk factors. Biomarkers reflecting immune activation and metabolic disturbance may reveal clinically relevant residual risk.
Objective: To examine whether routinely obtainable inflammatory and metabolic indices are related to subsequent major adverse cardiovascular events (MACE) in adults with T2DM.
Methods: We prospectively followed 120 adults with established T2DM at Rashid Latif Khan University Medical College, Lahore, Pakistan, from June 2025 to April 2026. Baseline testing comprised high-sensitivity C-reactive protein (hs-CRP), neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), glycated hemoglobin (HbA1c), lipid measures, and the triglyceride-glucose (TyG) index. The prespecified composite outcome was the first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal ischemic stroke. Time-to-event associations were estimated with Cox regression, and predictive discrimination was explored using receiver-operating characteristic analysis.
Results: Twenty-four participants (20.0%) reached the composite endpoint. Event-positive participants had less favorable inflammatory and metabolic profiles, characterized by higher hs-CRP, NLR, SII, HbA1c, triglycerides, and TyG index and lower HDL-C. After covariate adjustment, hs-CRP (aHR 1.13 per 1 mg/L), SII (aHR 1.09 per 100 units), HbA1c (aHR 1.29 per 1%), and TyG index (aHR 1.71 per unit) remained associated with MACE. Their combined model yielded an AUC of 0.86, with 83.3% sensitivity and 78.1% specificity.
Conclusion: A combined inflammatory–metabolic profile identified patients with T2DM who experienced subsequent cardiovascular events. hs-CRP, SII, HbA1c, and TyG index may provide complementary information when used alongside standard cardiovascular risk assessment.
Downloads
References
American Diabetes Association Professional Practice Committee. Cardiovascular disease and risk management: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S207-S238. doi:10.2337/dc25-S010.
Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21(1):74. doi:10.1186/s12933-022-01516-6.
Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31-55. doi:10.1016/j.immuni.2021.12.013.
Hoes LLF, Riksen NP, Geleijnse JM, de Groot MCH, van der Schouw YT, Visseren FLJ, et al. Relationship of neutrophil-to-lymphocyte ratio, in addition to C-reactive protein, with cardiovascular events in patients with type 2 diabetes. Diabetes Res Clin Pract. 2024;213:111727. doi:10.1016/j.diabres.2024.111727.
Dong G, Gan M, Xu S, Xie Y, Zhou M, et al. The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes. Cardiovasc Diabetol. 2023;22(1):267. doi:10.1186/s12933-023-01998-y.
Zhu B, Liu Y, Liu W, Cao C, Chen Y, Yi Y, et al. Association of neutrophil-to-lymphocyte ratio with all-cause and cardiovascular mortality in CVD patients with diabetes or pre-diabetes. Sci Rep. 2024;14:24324. doi:10.1038/s41598-024-74642-8.
Meng C, Liu K. Nonlinear association of the systemic immune-inflammatory index with mortality in diabetic patients. Front Endocrinol (Lausanne). 2024;15:1334811. doi:10.3389/fendo.2024.1334811.
Tang Y, Feng X, Liu N, Zhou Y, Wang Y, Chen Z, et al. Relationship between systemic immune inflammation index and mortality among US adults with different diabetic status. Exp Gerontol. 2024;185:112350. doi:10.1016/j.exger.2023.112350.
Chen C, Chen Y, Gao Q, Wei Q. Association of systemic immune inflammatory index with all-cause and cause-specific mortality among individuals with type 2 diabetes. BMC Cardiovasc Disord. 2023;23(1):596. doi:10.1186/s12872-023-03638-5.
Yang C, Yang Q, Xie Z, Peng X, Liu H, Xie C. Association of systemic immune-inflammation index with all-cause and cause-specific mortality among type 2 diabetes. Endocrine. 2024;84(2):399-411. doi:10.1007/s12020-023-03587-1.
Long Z, Du J. Prognostic value of the systemic immunity-inflammation index for cardiovascular and all-cause mortality in cardiovascular disease patients with diabetes or prediabetes. J Diabetes Investig. 2025;16(3):510-520. doi:10.1111/jdi.14383.
Wang H, Nie H, Bu G, Tong X, Bai X. Systemic immune-inflammation index and risk of all-cause, cardiovascular, and cardio-cerebrovascular mortality. Eur J Med Res. 2023;28(1):575. doi:10.1186/s40001-023-01529-1.
Tai S, Fu L, Zhang N, Yang R, Zhou Y, Xing Z, et al. Association of cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2022;21(1):161. doi:10.1186/s12933-022-01599-1.
Moon JH, Kim Y, Oh TJ, Moon JH, Kwak SH, Park KS, et al. Triglyceride-glucose index predicts future atherosclerotic cardiovascular diseases. Endocrinol Metab (Seoul). 2023;38(4):406-417. doi:10.3803/EnM.2023.1703.
Liu Q, Zhang Y, Chen S, Xiang H, Ouyang J, Liu H, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome. Cardiovasc Diabetol. 2024;23(1):80. doi:10.1186/s12933-024-02152-y.
Yin JL, Yang J, Song XJ, Qin X, Chang YJ, Chen X, et al. Triglyceride-glucose index and health outcomes: an umbrella review. Cardiovasc Diabetol. 2024;23(1):177. doi:10.1186/s12933-024-02241-y.
Chen Y, Xie K, Han Y, Ju H, Sun J, Zhao X. Triglyceride-glucose index combined with systemic inflammation indicators and mortality. Lipids Health Dis. 2024;23(1):289. doi:10.1186/s12944-024-02277-9.
Feng X, Deng Y, Chen C, Liu X, Huang Y, Feng Y. Predictive value of triglyceride-glucose index for all-cause and cardiovascular mortality in diabetes mellitus. Int J Endocrinol. 2024;2024:6417205. doi:10.1155/2024/6417205.
Kufazvinei TTJ, Chai J, Boden KA, Channon KM, Choudhury RP. Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes. Cardiovasc Res. 2024;120(11):1241-1252. doi:10.1093/cvr/cvae142.
Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic immune inflammation index, system inflammation response index and risk of all-cause and cardiovascular mortality. J Clin Med. 2023;12(3):1128. doi:10.3390/jcm12031128.
Zhang Y, Li X, Luo S, Liu C, Liu F, Chen X, et al. Association of triglyceride-glucose index with cardiovascular disease and mortality in patients with type 2 diabetes mellitus. Front Cardiovasc Med. 2024;11:1374210. doi:10.3389/fcvm.2024.1374210.
Downloads
PlumX Metrics
Published
Issue
Section
License
© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you must obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
How to Cite
